Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

Hospital Josep Trueta, Girona

CAP Peralada, Peralada

Hospital La Paz, Madrid

Hospial HM Montepríncipe, Boadilla del Monte

Hospital HM Puerta del Sur, Móstoles

Hospital Vall Hebron, Barcelona

CAP Centelles, Centelles